NCT00113802 2021-08-19Study of Epratuzumab (hLL2) in Patients With Waldenstrom's MacroglobulinemiaGilead SciencesPhase 2 Terminated31 enrolled
NCT00054834 2021-08-16Study of 90Y-hLL2 to Treat Non-Hodgkin's LymphomaGilead SciencesPhase 1 Terminated27 enrolled